Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.

Journal of medicinal chemistry - 10 Jul 2014

De Schutter Joris W, Park Jaeok, Leung Chun Yuen, Gormley Patrick, Lin Yih-Shyan, Hu Zheping, Berghuis Albert M, Poirier Judes, Tsantrizos Youla S

Abstract excerpt

Human farnesyl pyrophosphate synthase (hFPPS) is the gate-keeper of mammalian isoprenoids and the key target of bisphosphonate drugs. Bisphosphonates suffer from poor "drug-like" properties and are mainly effective in treating skeletal diseases. Recent investigations have implicated hFPPS in vari...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allosteric Site
Share to Catalytic Domain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diphosphonates

Share to Drug Evaluation, Preclinical

Share to Neurodegenerative Diseases

Share to Organophosphonates

Share to Pyrimidines

Share to tau Proteins

Source

Identifiers

PMID: 24911527
DOI: 10.1021/jm500629e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24911527-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.PMID 24911527Read ↗

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's diseaseSemantic proximity Read ↗

The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.Semantic proximity Read ↗

Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's diseaseSemantic proximity Read ↗

A specific non-bisphosphonate inhibitor of the bifunctional farnesyl/geranylgeranyl diphosphate synthase in malaria parasitesSemantic proximity Read ↗

Polyphosphate: A Conserved Modifier of Amyloidogenic ProcessesSemantic proximity Read ↗

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.Semantic proximity Read ↗

Inhibition of FicD-mediated AMPylation and deAMPylation by Isoprenoid DiphosphatesSemantic proximity Read ↗

Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.Semantic proximity Read ↗

Miglustat in Alzheimer's Disease Associated With Heterozygous NPC1 Mutation: Exploratory Case Series and Preliminary Findings.Semantic proximity Read ↗

Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides.Semantic proximity Read ↗

Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s DiseaseSemantic proximity Read ↗

Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.